BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34971948)

  • 21. MicroRNA-433 inhibits migration and invasion of ovarian cancer cells via targeting Notch1.
    Liang T; Guo Q; Li L; Cheng Y; Ren C; Zhang G
    Neoplasma; 2016; 63(5):696-704. PubMed ID: 27468873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer.
    Li X; Liu J; Sun H; Zou Y; Chen J; Chen Y; Chen C; Wu X
    Acta Biochim Pol; 2020 Jun; 67(2):165-172. PubMed ID: 32550700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mind bomb-2 is an E3 ligase for Notch ligand.
    Koo BK; Yoon KJ; Yoo KW; Lim HS; Song R; So JH; Kim CH; Kong YY
    J Biol Chem; 2005 Jun; 280(23):22335-42. PubMed ID: 15824097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA FEZF1-AS1 promotes non-small lung cancer cell migration and invasion through the up-regulation of NOTCH1 by serving as a sponge of miR-34a.
    Huang S; Li C; Huang J; Luo P; Mo D; Wang H
    BMC Pulm Med; 2020 Apr; 20(1):110. PubMed ID: 32349744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ca
    Zemoura K; Balakrishnan K; Grampp T; Benke D
    Mol Neurobiol; 2019 Feb; 56(2):1293-1309. PubMed ID: 29881949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas.
    Amodio N; Scrima M; Palaia L; Salman AN; Quintiero A; Franco R; Botti G; Pirozzi P; Rocco G; De Rosa N; Viglietto G
    Am J Pathol; 2010 Nov; 177(5):2622-34. PubMed ID: 20889565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
    Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
    Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective.
    Gao X; Cai Y; Wang Z; He W; Cao S; Xu R; Chen H
    J Transl Med; 2019 Sep; 17(1):308. PubMed ID: 31511014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-206 may suppress non-small lung cancer metastasis by targeting CORO1C.
    Liao M; Peng L
    Cell Mol Biol Lett; 2020; 25():22. PubMed ID: 32206066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway.
    Guo J; He L; Yuan P; Wang P; Lu Y; Tong F; Wang Y; Yin Y; Tian J; Sun J
    Oncol Rep; 2012 Nov; 28(5):1709-18. PubMed ID: 22940701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymosin beta 4 silencing suppresses proliferation and invasion of non-small cell lung cancer cells by repressing Notch1 activation.
    Huang D; Wang S; Wang A; Chen X; Zhang H
    Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):788-94. PubMed ID: 27521796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion.
    Hui L; Zhang S; Wudu M; Ren H; Xu Y; Zhang Q; Qiu X
    Thorac Cancer; 2019 Jun; 10(6):1479-1488. PubMed ID: 31124298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KIAA0247 inhibits growth, migration, invasion of non-small-cell lung cancer through regulating the Notch pathway.
    Xu Y; Ren H; Jiang J; Wang Q; Wudu M; Zhang Q; Su H; Wang C; Jiang L; Qiu X
    Cancer Sci; 2018 Apr; 109(4):1055-1065. PubMed ID: 29451718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer.
    Yue QY; Zhang Y
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1003-1010. PubMed ID: 29509248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA MIR155HG knockdown suppresses cell proliferation, migration and invasion in NSCLC by upregulating TP53INP1 directly targeted by miR-155-3p and miR-155-5p.
    Ren XY; Han YD; Lin Q
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4822-4835. PubMed ID: 32432745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growth.
    Ding XY; Ding J; Wu K; Wen W; Liu C; Yan HX; Chen C; Wang S; Tang H; Gao CK; Guo LN; Cao D; Li Z; Feng GS; Wang HY; Xu ZF
    Oncogene; 2012 Jun; 31(23):2899-906. PubMed ID: 22002304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
    Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
    Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA NEAT1 regulated cell proliferation, invasion, migration and apoptosis by targeting has-miR-376b-3p/SULF1 axis in non-small cell lung cancer.
    Chen LM; Niu YD; Xiao M; Li XJ; Lin H
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4810-4821. PubMed ID: 32432744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. circMTDH.4/miR-630/AEG-1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC.
    Li YH; Xu CL; He CJ; Pu HH; Liu JL; Wang Y
    Mol Carcinog; 2020 Feb; 59(2):141-153. PubMed ID: 31749230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.